Stay updated on RO6874281 for HER2-positive Cancer: Clinical Trial

Sign up to get notified when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RO6874281 for HER2-positive Cancer: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    v3.0.2 replaces v3.0.1, indicating a minor release; the Back to Top element was removed.
    Difference
    0.5%
    Check dated 2025-09-14T19:24:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.5%
    Check dated 2025-09-07T16:13:06.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.
    Difference
    63%
    Check dated 2025-08-31T12:02:36.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T05:04:21.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:45:46.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:00:26.000Z thumbnail image

Stay in the know with updates to RO6874281 for HER2-positive Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.